153 tracked 13F filers disclose a position in RGNX as of the latest SEC 13F filings, a combined $352.7M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | $48.5M | 5.8M | ▲+0.5% Added · +26K sh | Q1 2026 | |
| 2 | Redmile Group, LLC | $36.6M | 4.4M | —Held | Q1 2026 | |
| 3 | JPMORGAN CHASE & CO | $27.1M | 3.5M | ▼−2.0% Reduced · −70K sh | Q1 2026 | |
| 4 | STATE STREET CORP | $35.6M | 3.0M | ▲+8.8% Added · +240K sh | Q2 2026 | |
| 5 | MORGAN STANLEY | $17.3M | 2.1M | ▲+2.5% Added · +51K sh | Q1 2026 | |
| 6 | VANGUARD CAPITAL MANAGEMENT LLC | $16.8M | 2.0M | →First observed position No prior filed position | Q1 2026 | |
| 7 | GOLDMAN SACHS GROUP INC | $15.4M | 1.8M | ▲+3.0% Added · +54K sh | Q1 2026 | |
| 8 | Qube Research & Technologies Ltd | $11.0M | 1.3M | ▲+196% Added · +868K sh | Q1 2026 | |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | $14.9M | 1.2M | ▲+9.1% Added · +104K sh | Q2 2026 | |
| 10 | AQR CAPITAL MANAGEMENT LLC | $8.8M | 1.1M | ▼−23% Reduced · −310K sh | Q1 2026 | |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | $8.5M | 1.0M | →First observed position No prior filed position | Q1 2026 | |
| 12 | DIMENSIONAL FUND ADVISORS LP | $8.5M | 1.0M | ▲+12% Added · +107K sh | Q1 2026 | |
| 13 | Integral Health Asset Management, LLC | $9.6M | 800K | ▼−47% Reduced · −700K sh | Q2 2026 | |
| 14 | Nuveen, LLC | $4.9M | 582K | ▼−12% Reduced · −76K sh | Q1 2026 | |
| 15 | TWO SIGMA INVESTMENTS, LP | $4.6M | 555K | ▲+327% Added · +425K sh | Q1 2026 | |
| 16 | 22NW, LP | $5.9M | 493K | —Held | Q2 2026 | |
| 17 | Pale Fire Capital SE | $5.6M | 466K | ▼−5.6% Reduced · −28K sh | Q3 2026 | |
| 18 | NORTHERN TRUST CORP | $3.3M | 394K | ▲+5.3% Added · +20K sh | Q1 2026 | |
| 19 | STIFEL FINANCIAL CORP | $3.3M | 393K | ▲+17% Added · +58K sh | Q1 2026 | |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $3.3M | 391K | ▼−0.2% Reduced · −860 sh | Q1 2026 | |
| 21 | BANK OF AMERICA CORP /DE/ | $2.7M | 325K | ▲+8.1% Added · +24K sh | Q1 2026 | |
| 22 | VANGUARD FIDUCIARY TRUST CO | $2.6M | 312K | →First observed position No prior filed position | Q1 2026 | |
| 23 | FMR LLC | $2.6M | 311K | ▲+17% Added · +45K sh | Q1 2026 | |
| 24 | RENAISSANCE TECHNOLOGIES LLC | $2.6M | 305K | ▼−8.3% Reduced · −28K sh | Q1 2026 | |
| 25 | D. E. Shaw & Co., Inc. | $2.4M | 286K | ▲+318% Added · +218K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 8 funds opened a new position in RGNX and 18 added to an existing one, while 18 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| NVIDIA CORPNVDA | 73 funds | $221.7B |
| AMAZON.COM INCAMZN | 73 funds | $108.9B |
| ELI LILLY & COLLY | 72 funds | $41.9B |
| META PLATFORMS INC-CLASS AMETA | 71 funds | $63.8B |
| MICROSOFT CORPMSFT | 70 funds | $155.7B |
| MICRON TECHNOLOGY INCMU | 70 funds | $18.8B |
| ALPHABET INC-CL AGOOGL | 69 funds | $88.5B |
| COSTCO WHOLESALE CORPCOST | 69 funds | $19.6B |
| VISA INC-CLASS A SHARESV | 68 funds | $37.9B |
| LAM RESEARCH CORPLRCX | 68 funds | $17.6B |
| APPLIED MATERIALS INCAMAT | 68 funds | $15.9B |
| BOSTON SCIENTIFIC CORPBSX | 68 funds | $8.6B |
Ranked by how many of RGNX's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Aug 27, 2026 | Ciongoli Gregory Austin | Director | Buy (P) | 53K | $500K |
| Aug 26, 2026 | Ciongoli Gregory Austin | Director | Buy (P) | 49K | $450K |
| Jul 2, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell (S) | 2K | $29K |
| Jul 1, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell (S) | 37K | $472K |
| Jun 29, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell (S) | 20K | $216K |
| May 11, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell (S) | 15K | $169K |
| Mar 10, 2026 | PAKOLA STEVE | Chief Medical Officer | Sell (S) | 5K | $53K |
| Oct 9, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell (S) | 21K | $263K |
| Sep 29, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell (S) | 8K | $76K |
| Sep 10, 2025 | Simpson Curran | Chief Executive Officer, Director | Sell (S) | 8K | $77K |
| May 12, 2025 | Mills Kenneth T. | Director | Sell (S) | 21K | $163K |
| Oct 1, 2024 | KARABELAS ARGERIS N | Director | Sell (S) | 10K | $101K |
Connected entities for RGNX
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/RGNX/capital-change-brief"
Use Arkolith's capital_change_brief for RGNX. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for RGNX. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.